A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia.

Hong ZhengShin MineishiDavid ClaxtonJunjia ZhuChenchen ZhaoBei JiaW Christopher EhmannWitold B RybkaSeema NaikNatthapol SongdejJoseph J DrabickRaymond J Hohl

Published in: American journal of hematology (2020)

Keyphrases

acute myeloid leukemia
clinical trial
allogeneic hematopoietic stem cell transplantation
phase ii
open label
double blind
study protocol
randomized controlled trial
acute lymphoblastic leukemia
placebo controlled